UK markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
76.17-0.70 (-0.91%)
As of 3:59PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close76.87
Open76.93
Bid76.28 x 900
Ask76.29 x 1400
Day's range76.16 - 77.26
52-week range68.44 - 83.78
Volume8,148,417
Avg. volume11,671,270
Market cap192.867B
Beta (5Y monthly)0.42
PE ratio (TTM)34.69
EPS (TTM)2.20
Earnings date28 Oct 2021
Forward dividend & yield2.60 (3.38%)
Ex-dividend date14 Sept 2021
1y target est93.02
  • Editor's pick
    Yahoo Finance Video

    Doctor on COVID-19: 'People who are vaccinated are still very susceptible to infection'

    Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • Motley Fool

    Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?

    Merck (NYSE: MRK) recently won U.S. Food and Drug Administration approval for its pneumococcal vaccine. Pfizer (NYSE: PFE) currently dominates the pneumococcal vaccine market, with its Prevenar 13 generating nearly $6 billion in sales last year. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss whether or not Merck can beat Pfizer in this multibillion-dollar vaccine market.

  • Yahoo Finance Video

    Doctor on Delta variant: ’All of us are extremely concerned’

    Dr. Michael Gonzalez, Emergency Medicine Physician & Assistant Professor at Baylor College of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.